Efficacy, tolerability, and safety of oral paliperidone extended release in the treatment of schizophrenia: a 24-week, open-label, prospective switch study in different settings in Taiwan

PURPOSE: Paliperidone extended release (ER) is an oral psychotropic treatment formulated to release paliperidone at a controlled, gradually ascending rate. We evaluated the efficacy and safety of switching to paliperidone ER in Taiwanese patients with schizophrenia who were unresponsive or intoleran...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ching-Yen, Tang, Tze-Chun, Chen, Tzu-Ting, Bai, Ya Mei, Tsai, Huei-Huang, Chen, Hou-Liang, Huang, Chun-Jen, Chen, Chih-Ken, Chen, Chun-Chih, Hsiao, Mei-Chun, Liu, Chia-Yih, Yeh, Hong-Shiow, Chiu, Nan-Ying, Hsiao, Cheng-Chen, Chen, Cheng-Sheng, Su, Tung-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848663/
https://www.ncbi.nlm.nih.gov/pubmed/29563800
http://dx.doi.org/10.2147/NDT.S161186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848663/
https://www.ncbi.nlm.nih.gov/pubmed/29563800
http://dx.doi.org/10.2147/NDT.S161186

Ejemplares similares